These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Management of hemophilia]. Laurian Y Rev Prat; 1989 Dec; 39(30):2669-73. PubMed ID: 2515580 [TBL] [Abstract][Full Text] [Related]
3. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies. Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234 [No Abstract] [Full Text] [Related]
4. [New viewpoints in the treatment of hemophilia]. Göbel U Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442 [No Abstract] [Full Text] [Related]
6. Factor VIII inhibitors in hemophilia. Mariani G Bilt Hematol Transfuz; 1979; 7(1):3-41. PubMed ID: 121880 [No Abstract] [Full Text] [Related]
7. Current concepts in diagnosis and management of hemophilia. Aledort LM Hosp Pract (Off Ed); 1982 Oct; 17(10):77-84, 89-92. PubMed ID: 6811410 [No Abstract] [Full Text] [Related]
8. Hemophiliacs with inhibitors: therapeutic options. Roberts HR N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992 [No Abstract] [Full Text] [Related]
9. Treatment of hemophilia. Meili EO Schweiz Med Wochenschr Suppl; 1991; 43():82-9. PubMed ID: 1843043 [No Abstract] [Full Text] [Related]
10. Immunogenicity and immune tolerance coagulation Factors VIII and IX. Rup B Dev Biol (Basel); 2003; 112():55-9. PubMed ID: 12762504 [TBL] [Abstract][Full Text] [Related]
12. The past and future of haemophilia: diagnosis, treatments, and its complications. Peyvandi F; Garagiola I; Young G Lancet; 2016 Jul; 388(10040):187-97. PubMed ID: 26897598 [TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Hedner U Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747 [No Abstract] [Full Text] [Related]
15. Haemophilia and haemorrhagic disorders. Stevens R Practitioner; 1993 Apr; 237(1525):350-4. PubMed ID: 8351278 [No Abstract] [Full Text] [Related]
16. Haemophilia. Biggs R Proc R Soc Med; 1969 Sep; 62(9):913-4. PubMed ID: 4241884 [No Abstract] [Full Text] [Related]
17. Specific therapy in hemophilia. Hutaff LW N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809 [No Abstract] [Full Text] [Related]
18. [Substitution therapy with factor 8 and factor IX preparations]. Landbeck G Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465 [No Abstract] [Full Text] [Related]
19. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII]. Hrubisková K Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):672-82. PubMed ID: 6162735 [TBL] [Abstract][Full Text] [Related]
20. [Oral administration of factor VIII or IX concentrate preparation]. Sakuragawa N Rinsho Ketsueki; 1985 Jul; 26(7):1086-9. PubMed ID: 3932721 [No Abstract] [Full Text] [Related] [Next] [New Search]